Speaker illustration

Professor Maria Svensson

Uppsala University and Uppsala University Hospital, Uppsala (Sweden)

Member of:

European Society of Cardiology

Low-density lipoprotein cholesterol reduction with evolocumab and its use in clinical practice: evidence from swedish national register data

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Lipid-lowering by PCSK9 modulation: what’s new?

Thumbnail

A real-world analysis of characteristics and lipid-lowering therapy use in patients initiating treatment with evolocumab in Sweden

Event: ESC Congress 2021 - The Digital Experience

Topic: Drug therapy

Session: Risk Factors and Prevention ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk